Global Acromegaly Treatment Market Size To Exceed USD 3.52 Billion By 2035 | CAGR of 7.13%
Category: HealthcareGlobal Acromegaly Treatment Market Size To Exceed USD 3.52 Billion By 2035
According to a Research Report Published by Spherical Insights & Consulting, the Global Acromegaly Treatment Market Size is Expected to Grow from USD 1.65 Billion in 2024 to USD 3.52 Billion by 2035, at a CAGR of 7.13% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 285 pages with 127 Market data tables and figures & charts from the report on the "Global Acromegaly Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Somatostatin Analogs, GHRA, Dopamine Agonists, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/acromegaly-treatment-market
The Acromegaly Treatment Market Size refers to the industry of medicinal treatments used to address the symptoms brought on by this hormonal imbalance and reduce the body's excess growth hormone (GH) levels. Restoring normal GH and insulin-like growth factor 1 (IGF-1) levels, reducing symptoms, and avoiding negative outcomes are the main objectives of treatment. The market growth is driven by the developments in acromegaly treatments that are improving effectiveness and reducing side effects, are the more recent drug classes and tailored regimens. These advancements are driving improved patient outcomes and an increased demand for targeted solutions. The greater emphasis on personalized medicine is improving therapy accuracy and effectiveness. As a result of improved access to healthcare in developing countries, more patients are receiving timely care. However, the market growth is hindered by the high-expense medication.
The somatostatin analogs segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the projected period.
On the basis of drug class, the acromegaly treatment market is segmented into somatostatin analogs, GHRA, dopamine agonists, and others. Among these, the somatostatin analogs segment held the largest share in 2024 and is anticipated to grow at a significant CAGR during the projected period. The segmental growth can be attributed to their effectiveness in controlling growth hormone and managing symptoms. SSAs that significantly improve patient quality of life, such as octreotide, lanreotide, and pasireotide, are now part of the standard of care. Because of their ability to reduce tumor growth and restore hormone levels, they are the suggested choice for the long-term therapy of acromegaly.
The hospital pharmacies segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the estimated timeframe.
On the basis of distribution channel, the acromegaly treatment market is classified into hospital pharmacies, retail pharmacies, and others. Among these, the hospital pharmacies segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the estimated timeframe. The growth is driven by their essential role in hospital pharmacies in providing timely, specialized care. Hospital pharmacists provide advanced medications, such as somatostatin analogs and growth hormone receptor antagonists, which are essential for the effective treatment of acromegaly. Being close to medical personnel allows for timely therapy delivery and monitoring, which improves patient outcomes.
North America is anticipated to hold the largest share of the acromegaly treatment market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the acromegaly treatment market over the predicted timeframe. The regional growth can be attributed to its strong diagnostic capabilities and an advanced healthcare infrastructure that assists in the early detection and effective treatment of acromegaly. Easy access to cutting-edge medicines and greater awareness lead to better patient outcomes. The existence of big pharmaceutical companies fosters innovation in drug development. The greater access to treatments that comprehensive insurance coverage ensures reinforces the region's leadership in the global market for acromegaly treatments.
Asia Pacific is expected to grow at a rapid CAGR in the acromegaly treatment market during the forecast period. The region's growth is being driven by its quick economic expansion, rising healthcare costs, and improvements in healthcare infrastructure. Early diagnosis and a greater need for efficient therapies are the results of growing awareness of acromegaly. Numerous prospects for market expansion are presented by the sizable population and substantial unmet medical demands.
Major vendors in the global acromegaly treatment market are Novartis AG, Ionis Pharmaceuticals, Inc., Ipsen Pharma, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Dauntless Pharmaceuticals, Chiasma, Inc., WOCKHARDT, Peptron, Inc., Cipla Ltd., LG Chem, Teva Pharmaceutical Industries Ltd., BioPartners GmbH, Novo Nordisk A/S, Zydus Lifesciences Ltd., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In September 2024, Crinetics Pharmaceuticals filed a New Drug Application (NDA) with the FDA for paltusotine, a once-daily oral somatostatin receptor type 2 unique nonpeptide agonist. Paltusotine is being developed to treat and maintain acromegaly.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the acromegaly treatment market based on the below-mentioned segments:
Global Acromegaly Treatment Market, By Drug Class
- Somatostatin Analogs
- GHRA
- Dopamine Agonists
- Others
Global Acromegaly Treatment Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Acromegaly Treatment Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?